Literature DB >> 24484993

Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction.

Violanda Grigorescu1, Yujia Zhang2, Dmitry M Kissin2, Erin Sauber-Schatz2, Mithi Sunderam2, Russell S Kirby3, Hafsatou Diop4, Patricia McKane5, Denise J Jamieson2.   

Abstract

OBJECTIVE: To examine differences in maternal characteristics and pregnancy outcomes between women with ovulatory dysfunction (OD) and women with tubal obstruction (TO) who underwent assisted reproductive technology (ART).
DESIGN: Retrospective cohort study.
SETTING: Centers for Disease Control and Prevention. PATIENT(S): Exposed and nonexposed groups were selected from the 2000-2006 National ART Surveillance System linked with live-birth certificates from three states: Florida, Massachusetts, and Michigan. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Maternal characteristics and pregnancy outcomes, including newborn's health status right after delivery (Apgar score, <7 vs. ≥ 7) as the study outcome of interest, were assessed among women with OD/polycystic ovary syndrome (PCOS) and TO who used ART. RESULT(S): A significantly higher prevalence of women with OD/PCOS were younger (<35 years of age; 65.7% vs. 48.9%), were white (85.4% vs. 74.4%), had higher education (29.4% vs. 15.6%), and experienced diabetes (8.8% vs. 5.3%) compared with those having TO. The odds of having a lower (<7) Apgar score at 5 minutes were almost twice as high among newborns of women with OD/PCOS compared with those with TO (crude odds ratio, 1.86; 95% confidence interval [CI], 1.31, 2.64; adjusted odds ratio, 1.90; 95% CI, 1.30, 2.77). CONCLUSION(S): Women with OD/PCOS who underwent ART have different characteristics and health issues (higher prevalence of diabetes) and infant outcomes (lower Apgar score) compared with women with TO. Published by Elsevier Inc.

Entities:  

Keywords:  Apgar score; Ovulatory dysfunction (OD); assisted reproductive technology (ART); polycystic ovary syndrome (PCOS); tubal obstruction (TO)

Mesh:

Year:  2014        PMID: 24484993      PMCID: PMC4701028          DOI: 10.1016/j.fertnstert.2013.12.030

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  37 in total

1.  The continuing value of the Apgar score for the assessment of newborn infants.

Authors:  B M Casey; D D McIntire; K J Leveno
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  The Apgar score in the 21st century.

Authors:  L A Papile
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 3.  Polycystic ovarian syndrome.

Authors:  Khurshid A Khan; Sameer Stas; L Romayne Kurukulasuriya
Journal:  J Cardiometab Syndr       Date:  2006

Review 4.  Optimizing natural fertility.

Authors: 
Journal:  Fertil Steril       Date:  2008-11       Impact factor: 7.329

Review 5.  A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.

Authors:  C M Boomsma; M J C Eijkemans; E G Hughes; G H A Visser; B C J M Fauser; N S Macklon
Journal:  Hum Reprod Update       Date:  2006-08-04       Impact factor: 15.610

6.  Heritability of polycystic ovary syndrome in a Dutch twin-family study.

Authors:  J M Vink; S Sadrzadeh; C B Lambalk; D I Boomsma
Journal:  J Clin Endocrinol Metab       Date:  2005-10-11       Impact factor: 5.958

7.  Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance.

Authors:  Mark O Goodarzi; Manuel J Quiñones; Ricardo Azziz; Jerome I Rotter; Willa A Hsueh; Huiying Yang
Journal:  Fertil Steril       Date:  2005-09       Impact factor: 7.329

8.  Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.

Authors:  C K Welt; J A Gudmundsson; G Arason; J Adams; H Palsdottir; G Gudlaugsdottir; G Ingadottir; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2006-09-26       Impact factor: 5.958

9.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

10.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

View more
  12 in total

1.  Using multiple imputation to address the inconsistent distribution of a controlling variable when modeling an infrequent outcome.

Authors:  Yujia Zhang; Sara Crawford; Sheree L Boulet; Michael Monsour; Bruce Cohen; Patricia McKane; Karen Freeman
Journal:  J Mod Appl Stat Methods       Date:  2017

2.  Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment.

Authors:  Judy E Stern; Barbara Luke; Michael Tobias; Daksha Gopal; Mark D Hornstein; Hafsatou Diop
Journal:  Fertil Steril       Date:  2015-03-23       Impact factor: 7.329

Review 3.  Epigenetically regulated imprinted gene expression associated with IVF and infertility: possible influence of prenatal stress and depression.

Authors:  Julia F Litzky; Carmen J Marsit
Journal:  J Assist Reprod Genet       Date:  2019-05-24       Impact factor: 3.412

4.  Assisted reproductive outcomes of male cancer survivors.

Authors:  Ainhoa García; María Belén Herrero; Hananel Holzer; Togas Tulandi; Peter Chan
Journal:  J Cancer Surviv       Date:  2014-10-02       Impact factor: 4.442

Review 5.  Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome.

Authors:  Neil R Chappell; William E Gibbons; Chellakkan S Blesson
Journal:  Steroids       Date:  2022-02-18       Impact factor: 2.668

6.  Hyperandrogenemia alters mitochondrial structure and function in the oocytes of obese mouse with polycystic ovary syndrome.

Authors:  Neil R Chappell; Beth Zhou; Pardis Hosseinzadeh; Amy Schutt; William E Gibbons; Chellakkan S Blesson
Journal:  F S Sci       Date:  2020-12-10

7.  Assisted reproductive technology treatment increases obstetric and neonatal risks over that of the underlying infertility diagnosis.

Authors:  Judy E Stern; Chia-Ling Liu; Xiaohui Cui; Howard J Cabral; Leslie V Farland; Charles Coddington; Hafsatou Diop
Journal:  Fertil Steril       Date:  2022-04-07       Impact factor: 7.490

8.  Validation of birth outcomes from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS): population-based analysis from the Massachusetts Outcome Study of Assisted Reproductive Technology (MOSART).

Authors:  Judy E Stern; Daksha Gopal; Rebecca F Liberman; Marlene Anderka; Milton Kotelchuck; Barbara Luke
Journal:  Fertil Steril       Date:  2016-05-18       Impact factor: 7.329

9.  Birth Outcomes by Infertility Diagnosis Analyses of the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART).

Authors:  Barbara Luke; Judy E Stern; Milton Kotelchuck; Eugene R Declercq; Bruce Cohen; Hafsatou Diop
Journal:  J Reprod Med       Date:  2015 Nov-Dec       Impact factor: 0.142

10.  Embryo banking among women diagnosed with cancer: a pilot population-based study in New York, Texas, and Illinois.

Authors:  Barbara Luke; Morton B Brown; Logan G Spector; Judy E Stern; Yolanda R Smith; Melanie Williams; Lori Koch; Maria J Schymura
Journal:  J Assist Reprod Genet       Date:  2016-02-03       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.